NewEdge Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
1,397
+434
+45% +$38K ﹤0.01% 2706
2025
Q4
$81.7K Sell
963
-249
-21% -$19.9K ﹤0.01% 2820
2025
Q3
$87.9K Hold
1,212
﹤0.01% 2643
2025
Q2
$79.4K Sell
1,212
-951
-44% -$61.9K ﹤0.01% 2502
2025
Q1
$153K Sell
2,163
-23
-1% -$1.6K ﹤0.01% 2178
2024
Q4
$144K Sell
2,186
-831
-28% -$57.2K ﹤0.01% 2175
2024
Q3
$213K Sell
3,017
-816
-21% -$56.9K ﹤0.01% 1980
2024
Q2
$254K Sell
3,833
-324
-8% -$21.2K ﹤0.01% 1802
2024
Q1
$282K Sell
4,157
-187
-4% -$12.4K ﹤0.01% 1675
2023
Q4
$268K Buy
4,344
+3,387
+354% +$199K ﹤0.01% 1592
2023
Q3
$56.5K Sell
957
-300
-24% -$18.4K ﹤0.01% 2059
2023
Q2
$75K Hold
1,257
﹤0.01% 1951
2023
Q1
$73.4K Sell
1,257
-90
-7% -$5.42K ﹤0.01% 1856
2022
Q4
$84 Buy
+1,347
New +$81K ﹤0.01% 3395
2018
Q4
Sell
-5,520
Closed -$309K 669
2018
Q3
$309K Sell
5,520
-441
-7% -$24.1K 0.02% 486
2018
Q2
$300 Buy
+5,961
New +$296K 0.03% 412

Other funds holding IHE

NewEdge Advisors's IHE Position: Q1 2026 in Review

NewEdge Advisors increased its iShares US Pharmaceuticals ETF (IHE) stake by 45% in Q1 2026, buying an estimated $38K and bringing the position to 1,397 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

NewEdge Advisors first reported a position in IHE in Q2 2018 and has held it in 16 quarters since. The position peaked at $309K in Q3 2018. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • NewEdge Advisors held 1,397 shares of iShares US Pharmaceuticals ETF worth $121K as of Q1 2026.
  • NewEdge Advisors bought 434 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $38K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2706 holding.
  • NewEdge Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2018 and has held it in 16 quarters since.
  • NewEdge Advisors's iShares US Pharmaceuticals ETF position peaked at $309K in Q3 2018.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.